GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of reading API source threads from 2024 and half of it aged badly — 27 comments in the full submission. View in context.
633
c/compounding·submitted 1 months ago by u/lina_ndiaye

reading API source threads from 2024 and half of it aged badly

Discussionbranch of 9 comments

Been lurking in c/trialwatch for about 9 months and finally have something worth posting. Short version: week 3, 2.4mg, and compounding is the bit I still cannot get a straight answer on. I have read the wiki, I have read the last 25 threads, and the answers split roughly down the middle. What I actually want to know…

Read the full submission and all 27 comments →

This branch

9 comments, started 1 months ago
u/camila_sandvik60 points·1 months ago

Yeah, 503A and 503B are different regulatory animals.

replysharereportpermalink
u/quiet_moderatormod87 points·1 months ago

Strongly agree. API source transparency matters.

replysharereportpermalink
u/escrow_evangelist33 points·29 days ago

no pharmacy referral codes, naming is fine, recruiting is not

replysharereportpermalink
u/lina_ndiayeOP44 points·1 months ago

Respectfully this is a sample of one presented as a finding.

replysharereportpermalink
u/ruben_cabrera21 points·29 days ago

the Sweden situation is different from the US, different regulations

replysharereportpermalink
u/lina_ndiayeOP15 points·29 days ago

The telehealth + compounding combo cost API source plus 21% markup. Not cheap but covered by insurance depending on state.

replysharereportpermalink
u/zaid_grimaldi32 points·29 days ago

Not convinced. The evidence does not support that reading.

replysharereportpermalink
u/food_noise_gonemaintenance15 points·29 days ago

no pharmacy referral codes, naming is fine, recruiting is not

replysharereportpermalink
u/nadia_fonseca46 points·29 days ago

Slight fix: the number was 93.7, not 99.3. Decimal point, but a fairly consequential one.

replysharereportpermalink

← back to the whole thread

About c/compounding

Compounded GLP-1s as a supply route: the 503A/503B distinction, the shortage-list mechanics that made compounding legal and then didn't, state board rules, telehealth prescriber models, and what a compounding pharmacy will and will not tell you about its API source.

53kmembers
95submissions
Oct 2023created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
More in c/compounding
c/compounding rules
  1. Regulatory claims need a citation to the actual rule, notice or docket.
  2. No pharmacy referral codes. Naming a pharmacy is fine; recruiting for it is not.
  3. API source questions are on-topic and pharmacies dodging them is newsworthy.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/formulary_fighteru/usp_appendixu/quiet_moderatoru/prior_auth_pain
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →